Home Health News Seriously ill coronavirus patients in UK to receive rheumatoid arthritis drugs – Fox News

Seriously ill coronavirus patients in UK to receive rheumatoid arthritis drugs – Fox News

6 min read

U.K. government officials announced critically ill COVID-19 patients will soon receive rheumatoid arthritis drugs to boost recovery and odds of survival.

The news comes amid approval of a third coronavirus vaccine for Britain; Moderna’s vaccine will join an arsenal of previously authorized shots developed by Pfizer/BioNTech and Oxford/AstraZeneca.

In a statement, U.K. officials pointed to preliminary results from a study posted ahead of peer review, drawing on the government-backed international REMAP-CAP trial. 


Tocilizumab and sarilumab infused to seriously ill coronavirus patients soon after admittance to intensive care units dropped mortality risk by 24% and patients recovered up to 10 days faster. The vast majority of patients were also given a previously-authorized and widely-used cheap steroid called dexamethasone, which has already demonstrated improved survival for critically ill patients in need of oxygen.

U.K. officials hope that encouraging National Health Service providers to use tocilizumab, beginning Friday, will bring relief to burdened health systems amid a surge in cases linked to a mutated strain. The drug is already available in U.K. hospitals, and officials are working with the drug sponsor, Roche, to ensure continued supply, per the statement.


Health Secretary Matt Hancock said the drugs could save hundreds of lives.

“We have worked quickly to ensure this treatment is available to NHS patients without delay, meaning hundreds of lives will be saved,” Hancock said in the statement. “I am hugely proud of the significant role our NHS and its patients have played in this international trial, and grateful to the outstanding scientists and clinicians behind REMAP-CAP who have brought this treatment to our patients.”

In the trial, 353 patients received tocilizumab, 48 had sarilumab and 402 were in a control group. While hospital mortality was 36% among the control group, deaths dropped by 8% among patients receiving tocilizumab. The drug has seen mixed results, however, with the Italian Medicines Agency previously finding no benefit in terms of entry into intensive care or in terms of survival.

Meanwhile, last fall, the drug sponsor and Swiss pharmaceutical company Roche said people who received tocilizumab, marketed as Actemra/RoActemra, were 44% less likely to progress to the point where they would need to rely on life-support equipment, according to the company’s Phase 3 EMPACTA study.

Study lead Prof. Anthony Gordon of Imperial College London also lauded the results.

“This is a significant finding which could have immediate implications for the sickest patients with COVID-19,” he said in a university release.

These drugs are known as immunomodulators, and California pulmonary disease specialist Dr. Imran Sharief previously detailed to Fox News how the drugs work in coronavirus patients.


Coronavirus invades the body through receptors in the nasal passages and airways, Sharief had explained. Inflammatory mediators, such as Interleukin 6 (IL-6), then promote an inflammatory response which causes organ damage. The drug treats coronavirus by blocking the receptors and preventing the release of inflammatory mediators.

“I would suggest to my colleagues that once you see a deteriorating patient, a rapid deterioration in clinical status with high oxygen requirement or on the ventilator, try to start the medication as quickly as possible within first 12-24 hours,” Sharief said last spring.

Fox Business’ Daniella Genovese contributed to this report.

Let’s block ads! (Why?)

Source link


  1. Maricela Veile

    January 12, 2021 at 3:32 am

    Very nice post. I just stumbled upon your blog and wanted to say that I have really enjoyed surfing around your blog posts. In any case I will be subscribing to your feed and I hope you write again soon!


  2. asmr https://0mniartist.tumblr.com

    April 10, 2021 at 9:23 pm

    Hello! I could have sworn I’ve visited this web site before but after going through many of the posts I realized it’s new to me.
    Anyhow, I’m certainly pleased I discovered it and I’ll be book-marking it and checking back often! asmr 0mniartist


  3. asmr https://0mniartist.tumblr.com

    April 11, 2021 at 10:50 am

    Spot on with this write-up, I seriously think this website needs much more attention. I’ll probably be returning to read through more, thanks for the information! asmr 0mniartist


  4. 0mniartist

    April 12, 2021 at 5:17 pm

    Hi, I do believe this is a great web site. I stumbledupon it 😉 I will revisit yet again since i have saved
    as a favorite it. Money and freedom is the greatest way to change, may you be rich and continue to help other people.
    0mniartist asmr


  5. http://tinyurl.com/

    April 14, 2021 at 9:59 am

    Thanks for sharing your thoughts on asmr. Regards asmr


  6. tinyurl.com

    April 16, 2021 at 2:45 am

    Aw, this was a very good post. Taking a few minutes and actual effort to make a really good article… but what can I say… I put things off a whole lot and don’t manage to get anything done.
    asmr 0mniartist


Leave a Reply

Your email address will not be published. Required fields are marked *

Check Also

With obesity on the rise, the best diet may be tailored to our genes, experts say – ABC News

With the COVID-19 pandemic drawing more attention to America’s obesity problem, a gr…